Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Ovarian Neoplasms × Metformin × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Squamous Cell Carcinoma of Head and Neck 2 Obesity 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Diseases 1 Insulin Resistance 1 Inflammation 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Barrett Esophagus 1

Interventions

olaparib 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 fludarabine 3 X-Rays 2 Taxes 2 Platinum 2 Paclitaxel 2 Oncolytic Virotherapy 2 Letrozole 2 Hyperthermic Intraperitoneal Chemotherapy 2 Fluorodeoxyglucose F18 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Cisplatin 2 Carboplatin 2 Aspirin 2 1,2-diaminocyclohexaneplatinum II citrate 2 trastuzumab biosimilar HLX02 1 sodium thiosulfate 1 pertuzumab 1 pembrolizumab 1 palbociclib 1 niraparib 1 montelukast 1 gallium 68 PSMA-11 1 eribulin 1 entrectinib 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03378297 2024-10-30

IMPACT

Haukeland University Hospital

Phase EARLY_PHASE1 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡